Development of novel cyclic NGR peptide-daunomycin conjugates with dual targeting property

Beilstein Journal of Organic Chemistry
Andrea Angelo Pierluigi TripodiGábor Mező

Abstract

Cyclic NGR peptides as homing devices are good candidates for the development of drug conjugates for targeted tumor therapy. In our previous study we reported that the Dau=Aoa-GFLGK(c[KNGRE]-GG-)-NH2 conjugate has a significant antitumor activity against both CD13+ HT-1080 human fibrosarcoma and CD13- but integrin positive HT-29 human colon adenocarcinoma cells. However, it seems that the free ε-amino group of Lys in the cycle is not necessary for the biological activity. Therefore, we developed novel cyclic NGR peptide-daunomycin conjugates in which Lys was replaced by different amino acids (Ala, Leu, Nle, Pro, Ser). The exchange of the Lys residue in the cycle simplified the cyclization step and resulted in a higher yield. The new conjugates showed lower chemostability against deamidation of Asn than the control compound, thus they had lower selectivity to CD13+ cells. However, the cellular uptake and cytotoxic effect of Dau=Aoa-GFLGK(c[NleNGRE]-GG-)-NH2 was higher in comparison to the control especially on HT-29 cells. Therefore, this conjugate is more suitable for drug targeting with dual targeting property.

References

Feb 1, 1990·Journal of Protein Chemistry·B N ViolandN R Siegel
Jul 1, 1986·International Journal of Peptide and Protein Research·Y C MeinwaldH A Scheraga
Jun 21, 2005·Journal of Cellular and Molecular Medicine·Joyce E Rundhaug
Aug 22, 2008·The Journal of Physical Chemistry. a·Saron CatakManuel F Ruiz-López
Jan 13, 2010·The Journal of Biological Chemistry·Flavio CurnisAngelo Corti
Jan 14, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ayele H NegussieMatthew R Dreher
Jan 24, 2012·Anti-cancer Agents in Medicinal Chemistry·Mingming ZouWenfang Xu
Feb 21, 2013·Chemistry : a European Journal·Michele MingozziCesare Gennari
Jan 17, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Gábor MátéGyörgy Trencsényi
Jun 3, 2017·PloS One·Kata Nóra EnyediGábor Mező

❮ Previous
Next ❯

Citations

Aug 16, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Vladimíra PavlíčkováTomáš Ruml
Sep 12, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ryota KirikoshiOhgi Takahashi
Dec 11, 2019·Pathology Oncology Research : POR·Andrea Angelo Pierluigi TripodiJózsef Tóvári
Feb 11, 2021·International Journal of Molecular Sciences·Adina BorbélyGitta Schlosser
May 10, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Katarzyna StaszakKrzysztof Roszkowski

❮ Previous
Next ❯

Methods Mentioned

BETA
phage display
fluorescence microscopy
deamidation
flow cytometry
protein assay

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.